Justine Koenigsberg | Senior Vice President-Investor Relations |
Roger Tung | Chief Executive Officer |
Marc Becker | Chief Financial Officer |
Jim Cassella | Chief Development Officer |
Roy Buchanan | JMP Securities |
Farzin Haque | Jefferies |
Alex Lim | Mizuho |
Good morning and welcome to Concert Pharmaceuticals Second Quarter 2021 Investor Update. Like last quarter, our prepared comments today will be brief, so we can jump right into the Q&A portion of the call. Roger Tung, our CEO will provide the CTP-543 key highlights and then Marc Becker, our CFO will walk you through the second quarter financials.
We will then be joined by Nancy Stuart, our Chief Operating Officer; and Jim Cassella, our Chief Development Officer for the Q&A portion of the call.
As a reminder, today's discussion will include forward-looking statements about our future expectations, plans and prospects.